These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33883257)

  • 1. Amino acids and RagD potentiate mTORC1 activation in CD8
    Zhang Y; Hu H; Liu W; Yan SM; Li Y; Tan L; Chen Y; Liu J; Peng Z; Yuan Y; Huang W; Yu F; He X; Li B; Zhang H
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-36β Promotes CD8
    Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
    Front Immunol; 2019; 10():1803. PubMed ID: 31447838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordination of the leucine-sensing Rag GTPase cycle by leucyl-tRNA synthetase in the mTORC1 signaling pathway.
    Lee M; Kim JH; Yoon I; Lee C; Fallahi Sichani M; Kang JS; Kang J; Guo M; Lee KY; Han G; Kim S; Han JM
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5279-E5288. PubMed ID: 29784813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
    Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
    Gu M; Zhou X; Sohn JH; Zhu L; Jie Z; Yang JY; Zheng X; Xie X; Yang J; Shi Y; Brightbill HD; Kim JB; Wang J; Cheng X; Sun SC
    Nat Immunol; 2021 Feb; 22(2):193-204. PubMed ID: 33398181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction.
    Kim JH; Lee C; Lee M; Wang H; Kim K; Park SJ; Yoon I; Jang J; Zhao H; Kim HK; Kwon NH; Jeong SJ; Yoo HC; Kim JH; Yang JS; Lee MY; Lee CW; Yun J; Oh SJ; Kang JS; Martinis SA; Hwang KY; Guo M; Han G; Han JM; Kim S
    Nat Commun; 2017 Sep; 8(1):732. PubMed ID: 28963468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acids License Kinase mTORC1 Activity and Treg Cell Function via Small G Proteins Rag and Rheb.
    Shi H; Chapman NM; Wen J; Guy C; Long L; Dhungana Y; Rankin S; Pelletier S; Vogel P; Wang H; Peng J; Guan KL; Chi H
    Immunity; 2019 Dec; 51(6):1012-1027.e7. PubMed ID: 31668641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.
    Oshiro N; Rapley J; Avruch J
    J Biol Chem; 2014 Jan; 289(5):2658-74. PubMed ID: 24337580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mTORC1 by the Rag GTPases.
    Lama-Sherpa TD; Jeong MH; Jewell JL
    Biochem Soc Trans; 2023 Apr; 51(2):655-664. PubMed ID: 36929165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
    Nishida M; Yamashita N; Ogawa T; Koseki K; Warabi E; Ohue T; Komatsu M; Matsushita H; Kakimi K; Kawakami E; Shiroguchi K; Udono H
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.
    Thounaojam MC; Dudimah DF; Pellom ST; Uzhachenko RV; Carbone DP; Dikov MM; Shanker A
    Oncotarget; 2015 Oct; 6(32):32439-55. PubMed ID: 26431276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.
    Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
    Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
    Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome.
    Napolitano G; Di Malta C; Esposito A; de Araujo MEG; Pece S; Bertalot G; Matarese M; Benedetti V; Zampelli A; Stasyk T; Siciliano D; Venuta A; Cesana M; Vilardo C; Nusco E; Monfregola J; Calcagnì A; Di Fiore PP; Huber LA; Ballabio A
    Nature; 2020 Sep; 585(7826):597-602. PubMed ID: 32612235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-Induced State of Immunoparalysis Is Defined by Diminished CD8 T Cell-Mediated Antitumor Immunity.
    Danahy DB; Kurup SP; Winborn CS; Jensen IJ; Harty JT; Griffith TS; Badovinac VP
    J Immunol; 2019 Aug; 203(3):725-735. PubMed ID: 31189573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals.
    Jin J; Kim C; Xia Q; Gould TM; Cao W; Zhang H; Li X; Weiskopf D; Grifoni A; Sette A; Weyand CM; Goronzy JJ
    Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34145066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.